Search clinical trials for: Naltrexone Hydrochloride

Total 7727 results

San Diego State University

Recruiting

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

Placebo | Naltrexone

United States
Medical University of Lublin

Recruiting

Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia

Quality of Life | Vulvodynia | Naltrexone

Poland
University of California, San Francisco

Completed

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

Multiple Sclerosis

United States
Pfizer

Terminated

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Chronic Pain

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder

Binge-Eating Disorder

United States
Pfizer

Terminated

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Moderate-severe Pain

United States
Timothy Smith

Completed

The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations (TEST CANADA)

Opioid Intoxication

Canada
Yale University
National Center for Responsible Gaming

Completed

Investigation of Naltrexone for Pathological Gambling

Pathological Gambling

United States
University of Pennsylvania

Recruiting

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)

Giant Cell Arteritis | Microscopic Polyangiitis | Polyarteritis Nodosa | Granulomatosis With Polyangiitis | Takayasu Arteritis | Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Churg-Strauss Syndrome (CSS)

United States
Rosemary Claire Roden
Children's Miracle Network

Enrolling by invitation

Oral Naltrexone In Pediatric Eating Disorders (ONPED)

Bulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging Type

United States
Orexigen Therapeutics, Inc

Terminated

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

Obesity | Overweight

United States
University of Miami

Completed

Optimizing Pharmacotherapy for Bipolar Alcoholics

Alcohol Dependence | Bipolar Disorder

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment

Obesity | Binge-Eating Disorder

United States
Scilex Pharmaceuticals, Inc.

Completed

Pharmacokinetics of SP-104

Healthy

New Zealand
Eunice Kennedy Shriver National Institute of Child...

Unknown

Self-Injury: Diagnosis and Treatment

Self-Injurious Behavior | Mental Retardation

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Alcohol Pharmacotherapy for HIV+ Prisoners (INSPIRE)

Alcohol Dependence | Human Immunodeficiency Virus | AIDS | Hazardous Drinking | Problem Drinking

United States
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

Buprenorphine Transdermal Patches Pharmacokinetic Study

Chronic Pain

China
Pfizer

Terminated

Conversion to Embeda With Rescue Trial (ConvERT)

Pain | Chronic Disease

United States
Glenn-Milo Santos
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

Methamphetamine Use Disorder

United States
Alkermes, Inc.

Terminated

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Alcoholism | Opiate Dependence
Ensysce Biosciences
PRA Health Sciences

Completed

Study of PF614 Compared to OxyContin® in Healthy Volunteers (SAD)

Healthy

United States
Alkermes, Inc.

Completed

ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults

Alcoholism
Pfizer

Completed

Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

Chronic Pain | Analgesia | Opioid-related Disorders | Narcotic Abuse
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
Minia University

Completed

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

Cornea Ulcer

Egypt
Pfizer

Completed

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

Pain

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Opioid-Related Disorders | Heroin Dependence

United States, Russian Federation
University of Bern
University Hospital Inselspital, Berne

Completed

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

Neuroscience of Dreaming, Healthy

Switzerland
Pfizer

Completed

A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

Osteoarthritis | Chronic Pain

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Alcohol Drinking

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Breast Cancer Research Foundation; American Institute for Cancer Research; Hopkins-WellSpan...

Active, not recruiting

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study (A-NEW)

Breast Cancer | Overweight or Obesity

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Centre for Addiction and Mental Health

Unknown

Vivitrol Treatment for Cannabis Use Disorder

Cannabis Use Disorder

Canada
Drug Delivery Company, LLC DBA Akyso Pharmaceuticals
National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive...

Not yet recruiting

A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults

Opioid Use Disorder
State University of New York - Upstate Medical...
Cephalon

Completed

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) (vivitrol)

Alcohol Dependence | Schizophrenia | Schizoaffective Disorders | Bipolar Disorders

United States
Pfizer

Completed

Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users

Nondependent Opioid Abuse, Episodic

United States
University of Colorado, Denver

Withdrawn

In Hospital IM Naltrexone: A Pilot Study (IM-NTX)

Alcohol Use Disorder
Alkermes, Inc.

Completed

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

Alcoholism
Albert Einstein Healthcare Network

Not yet recruiting

Bridging ED to Outpatient AUD Therapy With Naltrexone

Alcohol Use Disorder

United States
University of Chicago
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Efficacy of Naltrexone in Women's Smoking Cessation

Smoking | Smoking Cessation

United States
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Low Dose Naltrexone in Psoriasis

Psoriasis

Pakistan
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
Alkermes, Inc.

Completed

ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults

Alcoholism
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
University of Alabama at Birmingham

Withdrawn

Immune Effects of Low-dose Naltrexone in ME/CFS

Fatigue Syndrome, Chronic

United States
Yale University
National Institutes of Health (NIH)

Completed

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

Hypoglycemia

United States
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
University of Wisconsin, Madison

Completed

Attenuation of Pain in Men and Women

Pain

United States
US Department of Veterans Affairs

Terminated

Pilot Study of Depot NTX in Homeless Veterans

Alcohol Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana

Marijuana Use

Search clinical trials for: Naltrexone Hydrochloride

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations